|
1
|
Savage N: Searching for the roots of brain
cancer. Nature. 561:S50–S51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahmed SU, Carruthers R, Gilmour L,
Yildirim S, Watts C and Chalmers AJ: Selective inhibition of
parallel DNA damage response pathways optimizes radiosensitization
of glioblastoma stem-like cells. Cancer Res. 75:4416–4428. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colwell N, Larion M, Giles AJ, Seldomridge
AN, Sizdahkhani S, Gilbert MR and Park DM: Hypoxia in the
glioblastoma microenvironment: Shaping the phenotype of cancer
stem-like cells. Neuro Oncol. 19:887–896. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu D, Potluri N, Lu J, Kim Y and
Rastinejad F: Structural integration in hypoxia-inducible factors.
Nature. 524:303–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenza GL: Hypoxia-inducible factors:
Mediators of cancer progression and targets for cancer therapy.
Trends Pharmacol Sci. 33:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sadri N and Zhang PJ: Hypoxia-inducible
factors: Mediators of cancer progression; Prognostic and
therapeutic targets in soft tissue sarcomas. Cancers (Basel).
5:320–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan F, Qing Q, Pan Q, Hu M, Yu H and Yue
X: Serum exosomal miR-301a as a potential diagnostic and prognostic
biomarker for human glioma. Cell Oncol (Dordr). 41:25–33. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue X, Cao D, Lan F, Pan Q, Xia T and Yu
H: MiR-301a is activated by the Wnt/β-catenin pathway and promotes
glioma cell invasion by suppressing SEPT7. Neuro Oncol.
18:1288–1296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan F, Yu H, Hu M, Xia T and Yue X:
miR-144-3p exerts anti-tumor effects in glioblastoma by targeting
c-Met. J Neurochem. 135:274–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu K, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan
G, Wang J, Li W, Cao Y, Shen X, et al: Hypoxia induces drug
resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6
feedback loop. Mol Ther. 2019.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Zhou Y, Xu Q, Shang J, Lu L and Chen G:
Crocin inhibits the migration, invasion, and epithelial-mesenchymal
transition of gastric cancer cells via miR-320/KLF5/HIF-1α
signaling. J Cell Physiol. 234:17876–17885. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Q, Li Y, Tan BB, Fan LQ, Yang PG and
Tian Y: HIF-1α induces multidrug resistance in gastric cancer cells
by inducing MiR-27a. PLoS One. 10:e01327462015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ke HL, Li WM, Lin HH, Hsu WC, Hsu YL,
Chang LL, Huang CN, Li CC, Chang HP, Yeh HC, et al:
Hypoxia-regulated MicroRNA-210 overexpression is associated with
tumor development and progression in upper tract urothelial
carcinoma. Int J Med Sci. 14:578–584. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He C, Wang L, Zhang J and Xu H:
Hypoxia-inducible microRNA-224 promotes the cell growth, migration
and invasion by directly targeting RASSF8 in gastric cancer. Mol
Cancer. 16:352017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ge X, Liu X, Lin F, Li P, Liu K, Geng R,
Dai C, Lin Y, Tang W, Wu Z, et al: MicroRNA-421 regulated by HIF-1α
promotes metastasis, inhibits apoptosis, and induces cisplatin
resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Oncotarget. 7:24466–24482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benej M, Pastorekova S and Pastorek J:
Carbonic anhydrase IX: Regulation and role in cancer. Subcell
Biochem. 75:199–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ziffels B, Stringhini M, Probst P, Fugmann
T, Sturm T and Neri D: Antibody-based delivery of cytokine payloads
to carbonic anhydrase IX leads to cancer cures in immunocompetent
tumor-bearing mice. Mol Cancer Ther. 18:1544–1554. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng W, Hao Y, He C, Li L and Zhu G:
Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer.
18:572019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nouraee N, Khazaei S, Vasei M, Razavipour
SF, Sadeghizadeh M and Mowla SJ: MicroRNAs contribution in tumor
microenvironment of esophageal cancer. Cancer Biomarkers.
16:367–376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao GY, Cheng CC, Chiang YS, Cheng WT,
Liu IH and Wu SC: Exosomal miR-10a derived from amniotic fluid stem
cells preserves ovarian follicles after chemotherapy. Sci Rep.
6:231202016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khalid MA, Achakzai IK, Ahmed Khan S,
Majid Z, Hanif FM, Iqbal J, Laeeq SM and Luck NH: The use of
karnofsky performance status (KPS) as a predictor of 3 month post
discharge mortality in cirrhotic patients. Gastroenterol Hepatol
Bed Bench. 11:301–305. 2018.PubMed/NCBI
|
|
25
|
Yue X, Lan F, Hu M, Pan Q, Wang Q and Wang
J: Downregulation of serum microRNA-205 as a potential diagnostic
and prognostic biomarker for human glioma. J Neurosurg.
124:122–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eustace A, Irlam JJ, Taylor J, Denley H,
Agrawal S, Choudhury A, Ryder D, Ord JJ, Harris AL, Rojas AM, et
al: Necrosis predicts benefit from hypoxia-modifying therapy in
patients with high risk bladder cancer enrolled in a phase III
randomised trial. Radiother Oncol. 108:40–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dang K and Myers KA: The role of
hypoxia-induced miR-210 in cancer progression. Int J Mol Sci.
16:6353–6372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang W, Ma J, Zhou W, Zhou X, Cao B, Fan D
and Hong L: Biological implications and clinical value of mir-210
in gastrointestinal cancer. Expert Rev Gastroenterol Hepatol.
11:539–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Camps C, Saini HK, Mole DR, Choudhry H,
Reczko M, Guerra-Assunção JA, Tian YM, Buffa FM, Harris AL,
Hatzigeorgiou AG, et al: Integrated analysis of microRNA and mRNA
expression and association with HIF binding reveals the complexity
of microRNA expression regulation under hypoxia. Mol Cancer.
13:282014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agrawal R, Pandey P, Jha P, Dwivedi V,
Sarkar C and Kulshreshtha R: Hypoxic signature of microRNAs in
glioblastoma: Insights from small RNA deep sequencing. BMC
Genomics. 15:6862014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irlam-Jones JJ, Eustace A, Denley H,
Choudhury A, Harris AL, Hoskin PJ and West CM: Expression of
miR-210 in relation to other measures of hypoxia and prediction of
benefit from hypoxia modification in patients with bladder cancer.
Br J Cancer. 115:571–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li D, Liu J, Guo B, Liang C, Dang L, Lu C,
He X, Cheung HY, Xu L, Lu C, et al: Osteoclast-derived exosomal
miR-214-3p inhibits osteoblastic bone formation. Nat Commun.
7:108722016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Munagala R, Aqil F and Gupta RC: Exosomal
miRNAs as biomarkers of recurrent lung cancer. Tumour Biol.
37:10703–10714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcinoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Matsumura T, Sugimachi K, Iinuma H,
Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano
Y, et al: Exosomal microRNA in serum is a novel biomarker of
recurrence in human colorectal cancer. Br J Cancer. 113:275–281.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi R, Wang PY, Li XY, Chen JX, Li Y,
Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W and Cheng SJ: Exosomal
levels of miRNA-21 from cerebrospinal fluids associated with poor
prognosis and tumor recurrence of glioma patients. Oncotarget.
6:26971–26981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang X, Yuan T, Liang M, Du M, Xia S,
Dittmar R, Wang D, See W, Costello BA, Quevedo F, et al: Exosomal
miR-1290 and miR-375 as prognostic markers in castration-resistant
prostate cancer. Eur Urol. 67:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoshikawa M, Iinuma H, Umemoto Y,
Yanagisawa T, Matsumoto A and Jinno H: Exosome-encapsulated
microRNA-223-3p as a minimally invasive biomarker for the early
detection of invasive breast cancer. Oncol Lett. 15:9584–9592.
2018.PubMed/NCBI
|
|
41
|
Yang H, Fu H, Wang B, Zhang X, Mao J, Li
X, Wang M, Sun Z, Qian H and Xu W: Exosomal miR-423-5p targets SUFU
to promote cancer growth and metastasis and serves as a novel
marker for gastric cancer. Mol Carcinog. 57:1223–1236. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bavelloni A, Ramazzotti G, Poli A, Piazzi
M, Focaccia E, Blalock W and Faenza I: MiRNA-210: A current
overview. Anticancer Res. 37:6511–6521. 2017.PubMed/NCBI
|
|
43
|
Ren CX, Leng RX, Fan YG, Pan HF, Wu CH and
Ye DQ: MicroRNA-210 and its theranostic potential. Expert Opin Ther
Targets. 20:1325–1338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonora M, Wieckowsk MR, Chinopoulos C,
Kepp O, Kroemer G, Galluzzi L and Pinton P: Molecular mechanisms of
cell death: Central implication of ATP synthase in mitochondrial
permeability transition. Oncogene. 34:16082015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang S, Lai N, Liao K, Sun J and Lin Y:
MicroRNA-210 regulates cell proliferation and apoptosis by
targeting regulator of differentiation 1 in glioblastoma cells.
Folia Neuropathol. 53:236–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kulshreshtha R, Ferracin M, Wojcik SE,
Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM,
Negrini M, et al: A microRNA signature of hypoxia. Mol Cell Biol.
27:1859–1867. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ying Q, Liang L, Guo W, Zha R, Tian Q,
Huang S, Yao J, Ding J, Bao M, Ge C, et al: Hypoxia-inducible
microRNA-210 augments the metastatic potential of tumor cells by
targeting vacuole membrane protein 1 in hepatocellular carcinoma.
Hepatology. 54:2064–2075. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cheng HH, Mitchell PS, Kroh EM, Dowell AE,
Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan
AM, et al: Circulating microRNA profiling identifies a subset of
metastatic prostate cancer patients with evidence of
cancer-associated hypoxia. PLoS One. 8:e692392013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Martin RC, Gerstenecker A, Nabors LB,
Marson DC and Triebel KL: Impairment of medical decisional capacity
in relation to karnofsky performance status in adults with
malignant brain tumor. Neurooncol Pract. 2:13–19. 2015.PubMed/NCBI
|
